Opportunity Overview
Aptamers are single stranded oligonucleotides with defined secondary structures. They are raised against select targets by Systematic Evolution of Ligands by Exponential enrichment (SELEX), resulting in high affinity and selectivity for their chosen target and allowing aptamers to gain much traction as alternatives to antibodies in the field of theranostics. G protein-coupled receptors (GPCRs) are transmembrane proteins that bind extracellular agonists, then transduce these signals across the plasma membrane to activate intracellular signalling cascades via G proteins and -arrestins. Class B1 GPCRs respond to peptide hormones and have substantial extracellular domains to facilitate the binding of their agonist ligands and subsequent conformational shifts that allow transmembrane signal transduction. This large extracellular region could act as a large surface across which aptamers may form extensive and selective interactions without need to cross the plasma membrane. Few aptamers have been raised against GPCRs, with only one Class B1 GPCR having been targeted: the glucagon receptor (GCGR). This GPCR mediates the hyperglycaemic effects of glucagon in the pancreas. Even fewer of these GPCR-targeting aptamers have been characterised in their ability to affect GPCR signalling; however, aptamers raised against the 2 adrenoceptor are selective for distinct conformational states of this receptor. This suggests that aptamers could drive GPCRs into receptor states with unique signalling profiles, allowing for tight control of target receptor signalling. For disease-implicated receptors, this could prevent pathogenic signalling and encourage health-promoting signalling pathways. The beginning of this project will investigate the pharmacological effects of the known GCGR-targeting aptamer. This will utilise bioluminescence resonance energy transfer (BRET)-based assays, for example using labelled G...
This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | BBSRC |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2023 |
| Procurement stage | Active solicitation |
| Response due | September 29, 2027 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.